WO2004043474A3 - Verwendung eines oder mehrerer der elemente aus der gruppe yttrium, neodym und zirconium - Google Patents

Verwendung eines oder mehrerer der elemente aus der gruppe yttrium, neodym und zirconium Download PDF

Info

Publication number
WO2004043474A3
WO2004043474A3 PCT/EP2003/012532 EP0312532W WO2004043474A3 WO 2004043474 A3 WO2004043474 A3 WO 2004043474A3 EP 0312532 W EP0312532 W EP 0312532W WO 2004043474 A3 WO2004043474 A3 WO 2004043474A3
Authority
WO
WIPO (PCT)
Prior art keywords
elements
neodymium
zirconium
group containing
containing yttrium
Prior art date
Application number
PCT/EP2003/012532
Other languages
English (en)
French (fr)
Other versions
WO2004043474A2 (de
Inventor
Claus Harder
Bernd Heublein
Original Assignee
Biotronik Gmbh & Co Kg
Claus Harder
Bernd Heublein
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US10/535,084 priority Critical patent/US20060246107A1/en
Application filed by Biotronik Gmbh & Co Kg, Claus Harder, Bernd Heublein filed Critical Biotronik Gmbh & Co Kg
Priority to DE50309382T priority patent/DE50309382D1/de
Priority to AU2003288029A priority patent/AU2003288029A1/en
Priority to EP03779881A priority patent/EP1562565B1/de
Publication of WO2004043474A2 publication Critical patent/WO2004043474A2/de
Publication of WO2004043474A3 publication Critical patent/WO2004043474A3/de
Priority to US12/575,613 priority patent/US20100119576A1/en
Priority to US12/575,596 priority patent/US20100034899A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/02—Inorganic materials
    • A61L31/022—Metals or alloys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • A61F2/915—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/148—Materials at least partially resorbable by the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • A61F2/915—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
    • A61F2002/9155—Adjacent bands being connected to each other

Abstract

Die Erfindung betrifft die medizinische Verwendung eines oder mehrerer der Elemente aus der Gruppe Yttrium, Neodym und Zirconium, pharmazeutische Formulierungen, die diese Elemente enthalten, sowie Implantate, die zumindest bereichsweise aus diesen Formulierungen aufgebaut sind. Es hat sich u. a. gezeigt, dass eine eines oder mehrerer der Elemente enthaltende Formulierung eine die Proliferation von humanen glatten Muskelzellen hemmende Wirkung hat.
PCT/EP2003/012532 2002-11-13 2003-11-10 Verwendung eines oder mehrerer der elemente aus der gruppe yttrium, neodym und zirconium WO2004043474A2 (de)

Priority Applications (6)

Application Number Priority Date Filing Date Title
US10/535,084 US20060246107A1 (en) 2002-11-13 2003-10-11 Use of one or more elements from the group containing yttrium, neodymium and zirconium and pharmaceutical compositions containing said elements
DE50309382T DE50309382D1 (de) 2002-11-13 2003-11-10 Verwendung eines oder mehrerer der elemente aus der gruppe yttrium, neodym und zirconium
AU2003288029A AU2003288029A1 (en) 2002-11-13 2003-11-10 Use of one or more elements from the group containing yttrium, neodymium and zirconium
EP03779881A EP1562565B1 (de) 2002-11-13 2003-11-10 Verwendung eines oder mehrerer der elemente aus der gruppe yttrium, neodym und zirconium
US12/575,613 US20100119576A1 (en) 2002-11-13 2009-10-08 Use of one or more of the elements from the group yttrium, neodymium and zirconium, and pharmaceutical compositions which contain those elements
US12/575,596 US20100034899A1 (en) 2002-11-13 2009-10-08 Use of one or more of the elements from the group yttrium, neodymium and zirconium, and pharmaceutical compositions which contain those elements

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10253634A DE10253634A1 (de) 2002-11-13 2002-11-13 Endoprothese
DE10253634.1 2002-11-13

Related Child Applications (2)

Application Number Title Priority Date Filing Date
US12/575,596 Division US20100034899A1 (en) 2002-11-13 2009-10-08 Use of one or more of the elements from the group yttrium, neodymium and zirconium, and pharmaceutical compositions which contain those elements
US12/575,613 Division US20100119576A1 (en) 2002-11-13 2009-10-08 Use of one or more of the elements from the group yttrium, neodymium and zirconium, and pharmaceutical compositions which contain those elements

Publications (2)

Publication Number Publication Date
WO2004043474A2 WO2004043474A2 (de) 2004-05-27
WO2004043474A3 true WO2004043474A3 (de) 2005-01-13

Family

ID=32115564

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2003/012532 WO2004043474A2 (de) 2002-11-13 2003-11-10 Verwendung eines oder mehrerer der elemente aus der gruppe yttrium, neodym und zirconium

Country Status (7)

Country Link
US (4) US20060246107A1 (de)
EP (2) EP1419793B1 (de)
JP (1) JP5073913B2 (de)
AT (2) ATE316390T1 (de)
AU (1) AU2003288029A1 (de)
DE (3) DE10253634A1 (de)
WO (1) WO2004043474A2 (de)

Families Citing this family (149)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6306166B1 (en) * 1997-08-13 2001-10-23 Scimed Life Systems, Inc. Loading and release of water-insoluble drugs
AU2002345328A1 (en) 2001-06-27 2003-03-03 Remon Medical Technologies Ltd. Method and device for electrochemical formation of therapeutic species in vivo
US7842083B2 (en) 2001-08-20 2010-11-30 Innovational Holdings, Llc. Expandable medical device with improved spatial distribution
DE10253634A1 (de) * 2002-11-13 2004-05-27 Biotronik Meß- und Therapiegeräte GmbH & Co. Ingenieurbüro Berlin Endoprothese
CA2527975C (en) * 2003-06-13 2011-08-09 Mnemoscience Gmbh Biodegradable stents comprising a shape memory polymeric material
DE10361942A1 (de) * 2003-12-24 2005-07-21 Restate Patent Ag Radioopaker Marker für medizinische Implantate
DE10361941A1 (de) * 2003-12-24 2005-07-28 Restate Patent Ag Magnesiumhaltige Beschichtung
DE102004029611A1 (de) 2004-02-06 2005-08-25 Restate Patent Ag Implantat zur Freisetzung eines Wirkstoffs in ein von einem Körpermedium durchströmtes Gefäß
WO2005075005A1 (de) * 2004-02-06 2005-08-18 Biotronik Vi Patent Ag IMPLANTAT ZUR FREISETZUNG EINES WIRKSTOFFS IN EIN VON EINEM KÖRPERMEDIUM DURCHSTRÖMTES GEFÄß
DE102004026104A1 (de) * 2004-05-25 2005-12-15 Restate Patent Ag Implantat zur Gefäßligatur
WO2005118019A1 (en) * 2004-05-28 2005-12-15 Cook Incorporated Implantable bioabsorbable valve support frame
EP1618919B1 (de) * 2004-07-20 2012-07-04 Biotronik CRM Patent AG Fixierung für implantierbare Elektroden und Katheter
DE102004035904A1 (de) * 2004-07-20 2006-02-16 Biotronik Vi Patent Ag Implantierbare Elektrode
DE102004036399A1 (de) * 2004-07-23 2006-02-16 Biotronik Vi Patent Ag Biokompatibles und bioabsorbierbares Naht- und Klammermaterial für chirurgische Zwecke
DE102004043232A1 (de) * 2004-09-07 2006-03-09 Biotronik Vi Patent Ag Endoprothese aus einer Magnesiumlegierung
DE502005008226D1 (de) 2004-09-07 2009-11-12 Biotronik Vi Patent Ag Endoprothese aus einer Magnesiumlegierung
US9468704B2 (en) 2004-09-07 2016-10-18 Biotronik Vi Patent Ag Implant made of a biodegradable magnesium alloy
EP2169090B3 (de) 2008-09-30 2014-06-25 Biotronik VI Patent AG Implantat aus einer biologisch abbaubaren Magnesiumlegierung
DE102004043231A1 (de) * 2004-09-07 2006-03-09 Biotronik Vi Patent Ag Endoprothese aus einer Magnesiumlegierung
DE102004044679A1 (de) * 2004-09-09 2006-03-16 Biotronik Vi Patent Ag Implantat mit geringer Radialfestigkeit
JP2006167078A (ja) * 2004-12-15 2006-06-29 Terumo Corp 医療用インプラント
DE102005003188A1 (de) 2005-01-20 2006-07-27 Restate Patent Ag Medizinisches Implantat aus einer amorphen oder nanokristallinen Legierung
US8293261B2 (en) * 2005-01-28 2012-10-23 Terumo Kabushiki Kaisha Intravascular implant
US20060198869A1 (en) * 2005-03-03 2006-09-07 Icon Medical Corp. Bioabsorable medical devices
DE102005013221A1 (de) * 2005-03-17 2006-09-21 Biotronik Vi Patent Ag System zur Behandlung ausgedehnter obliterierender Erkrankungen eines Gefäßes
DE102005018356B4 (de) * 2005-04-20 2010-02-25 Eurocor Gmbh Resorbierbare Implantate
US20070010740A1 (en) * 2005-05-19 2007-01-11 Biophan Technologies, Inc. Electromagnetic resonant circuit sleeve for implantable medical device
DE102005031361A1 (de) 2005-06-30 2007-01-04 Biotronik Vi Patent Ag Verwendung von Propolis als Beschichtungsmaterial für medizinische Implantate
DE102005031868A1 (de) * 2005-07-04 2007-01-18 Biotronik Vi Patent Ag Arzneimitteldepot zur parenteralen, insbesondere intravaskulären Arzneimittelfreisetzung
US20070050009A1 (en) * 2005-08-30 2007-03-01 Aiden Flanagan Bioabsorbable stent
US8663308B2 (en) * 2005-09-19 2014-03-04 Cook Medical Technologies Llc Graft with bioabsorbable support frame
DE102005050344A1 (de) 2005-10-20 2007-05-03 Siemens Ag Kryokatheter zur Einführung in ein Körpergefäß sowie medizinische Untersuchungs- und Behandlungsvorrichtung
US20070135908A1 (en) * 2005-12-08 2007-06-14 Zhao Jonathon Z Absorbable stent comprising coating for controlling degradation and maintaining pH neutrality
DE102005059262B4 (de) 2005-12-12 2008-02-07 Siemens Ag Kathetervorrichtung
DE102005059271B4 (de) * 2005-12-12 2019-02-21 Siemens Healthcare Gmbh Kathetervorrichtung
DE102005059261B4 (de) 2005-12-12 2013-09-05 Siemens Aktiengesellschaft Kathetervorrichtung zur Behandlung eines teilweisen und/oder vollständigen Gefässverschlusses und Röntgeneinrichtung
US8840660B2 (en) 2006-01-05 2014-09-23 Boston Scientific Scimed, Inc. Bioerodible endoprostheses and methods of making the same
DE502006003003D1 (de) * 2006-01-10 2009-04-16 Acrostak Corp Bvi Implantat zur Behandlung der Innenwände eines Resektionshohlraumes
US8089029B2 (en) 2006-02-01 2012-01-03 Boston Scientific Scimed, Inc. Bioabsorbable metal medical device and method of manufacture
DE102006011348B4 (de) * 2006-03-11 2015-10-08 Biotronik Vi Patent Ag Verfahren zur Erzeugung einer in physiologischer Umgebung korrosionshemmenden Schicht auf einem Formkörper
EP1835042A1 (de) * 2006-03-18 2007-09-19 Acrostak Corp. Magnesium-Legierung mit verbesserter Kombination der mechanischen Eigenschaften und des Korrosionsverhaltens
WO2007107286A2 (en) * 2006-03-18 2007-09-27 Acrostak Corp. Bvi Magnesium-based alloy with improved combination of mechanical and corrosion characteristics
DE102006015457A1 (de) * 2006-03-31 2007-10-04 Biotronik Vi Patent Ag Magnesiumlegierung und dazugehöriges Herstellungsverfahren
US20070239253A1 (en) * 2006-04-06 2007-10-11 Jagger Karl A Oscillation assisted drug elution apparatus and method
US8048150B2 (en) 2006-04-12 2011-11-01 Boston Scientific Scimed, Inc. Endoprosthesis having a fiber meshwork disposed thereon
US20090081313A1 (en) * 2006-04-28 2009-03-26 Biomagnesium Systems Ltd. Biodegradable Magnesium Alloys and Uses Thereof
US20070282432A1 (en) * 2006-05-31 2007-12-06 Stinson Jonathan S Implantable medical endoprostheses
US20070288085A1 (en) * 2006-05-31 2007-12-13 Furst Joseph G Absorbable medical devices with specific design features
US9265865B2 (en) * 2006-06-30 2016-02-23 Boston Scientific Scimed, Inc. Stent having time-release indicator
US20080015578A1 (en) * 2006-07-12 2008-01-17 Dave Erickson Orthopedic implants comprising bioabsorbable metal
JP2009545407A (ja) 2006-08-02 2009-12-24 ボストン サイエンティフィック サイムド，インコーポレイテッド 三次元分解制御を備えたエンドプロテーゼ
DE102006038236A1 (de) * 2006-08-07 2008-02-14 Biotronik Vi Patent Ag Biodegradierbarer Stent mit einer aktiven Beschichtung
DE102006038241A1 (de) * 2006-08-07 2008-02-14 Biotronik Vi Patent Ag Stent mit einer genisteinhaltigen Beschichtung oder Kavitätenfüllung
DE102006038231A1 (de) 2006-08-07 2008-02-14 Biotronik Vi Patent Ag Implantat aus einem biokorrodierbaren metallischen Werkstoff mit einer Beschichtung aus einer Organosiliziumverbindung
DE102006038233A1 (de) * 2006-08-07 2008-02-14 Biotronik Vi Patent Ag Markerkomposit für medizinische Implantate
DE102006040936A1 (de) * 2006-08-31 2008-03-13 Siemens Ag Katheter zum Entfernen von Gewebe aus einem Hohlorgan
WO2008034030A2 (en) * 2006-09-15 2008-03-20 Boston Scientific Limited Magnetized bioerodible endoprosthesis
ES2368125T3 (es) 2006-09-15 2011-11-14 Boston Scientific Scimed, Inc. Endoprótesis bioerosionable con capas inorgánicas bioestables.
US8808726B2 (en) 2006-09-15 2014-08-19 Boston Scientific Scimed. Inc. Bioerodible endoprostheses and methods of making the same
WO2008034050A2 (en) * 2006-09-15 2008-03-20 Boston Scientific Limited Endoprosthesis containing magnetic induction particles
JP2010503485A (ja) 2006-09-15 2010-02-04 ボストン サイエンティフィック リミテッド 医療用デバイスおよび同デバイスの製造方法
JP2010503490A (ja) 2006-09-15 2010-02-04 ボストン サイエンティフィック リミテッド 調整可能な表面特徴を備えた内部人工器官
ATE517590T1 (de) 2006-09-15 2011-08-15 Boston Scient Ltd Biologisch erodierbare endoprothesen
US8002821B2 (en) 2006-09-18 2011-08-23 Boston Scientific Scimed, Inc. Bioerodible metallic ENDOPROSTHESES
AU2007297991B2 (en) * 2006-09-22 2011-02-17 U & I Corporation Implants comprising biodegradable metals and method for manufacturing the same
FR2906454B1 (fr) * 2006-09-28 2009-04-10 Perouse Soc Par Actions Simpli Implant destine a etre place dans un conduit de circulation du sang.
WO2008059968A1 (fr) 2006-11-17 2008-05-22 National Institute For Materials Science Dispositif médical à base de magnésium et son procédé de fabrication
US7651527B2 (en) * 2006-12-15 2010-01-26 Medtronic Vascular, Inc. Bioresorbable stent
DE102006060501A1 (de) 2006-12-19 2008-06-26 Biotronik Vi Patent Ag Verfahren zur Herstellung einer korrosionshemmenden Beschichtung auf einem Implantat aus einer biokorrodierbaren Magnesiumlegierung sowie nach dem Verfahren hergestelltes Implantat
ATE488259T1 (de) 2006-12-28 2010-12-15 Boston Scient Ltd Bioerodierbare endoprothesen und herstellungsverfahren dafür
CA2743022C (en) 2007-01-21 2012-10-09 Hemoteq Ag Methods for coating catheter balloons with a defined quantity of active agent
KR20090122202A (ko) 2007-01-30 2009-11-26 헤모텍 아게 생분해성 혈관 지지체
DE102007034350A1 (de) 2007-07-24 2009-01-29 Hemoteq Ag Biologisch abbaubare Gefäßstütze
DE102007008479A1 (de) * 2007-02-21 2008-09-04 Orlowski, Michael, Dr. Beschichtetes Expandierbares System
US20080243234A1 (en) * 2007-03-27 2008-10-02 Medtronic Vascular, Inc. Magnesium Alloy Stent
US20080249608A1 (en) * 2007-04-04 2008-10-09 Vipul Dave Bioabsorbable Polymer, Bioabsorbable Composite Stents
AU2008252907A1 (en) * 2007-05-22 2008-11-27 Cinvention Ag Partially degradable scaffolds for biomedical applications
DK2000551T3 (da) 2007-05-28 2011-01-10 Acrostak Corp Bvi Magnesium-baserede legeringer
DE102007030438A1 (de) 2007-06-29 2009-01-08 Biotronik Vi Patent Ag Implantat aus einer biokorrodierbaren Magnesiumlegierung und mit einer Beschichtung aus einem Poly(orthoester)
US9192697B2 (en) 2007-07-03 2015-11-24 Hemoteq Ag Balloon catheter for treating stenosis of body passages and for preventing threatening restenosis
DE102007038799A1 (de) 2007-08-17 2009-02-19 Biotronik Vi Patent Ag Implantat aus einer biokorrodierbaren Magnesiumlegierung und mit einer Beschichtung aus einem biokorrodierbaren Polyphosphazen
US8052745B2 (en) 2007-09-13 2011-11-08 Boston Scientific Scimed, Inc. Endoprosthesis
US8118857B2 (en) 2007-11-29 2012-02-21 Boston Scientific Corporation Medical articles that stimulate endothelial cell migration
DE102007061647A1 (de) 2007-12-20 2009-07-02 Biotronik Vi Patent Ag Implantat mit einem Grundkörper aus einer biokorrodierbaren Legierung
US8801778B2 (en) 2007-12-20 2014-08-12 Biotronik Vi Patent Ag Implant with a base body of a biocorrodible alloy
DE102008006455A1 (de) 2008-01-29 2009-07-30 Biotronik Vi Patent Ag Implantat mit einem Grundkörper aus einer biokorrodierbaren Legierung und einer korrosionshemmenden Beschichtung
DE102008006654A1 (de) * 2008-01-30 2009-08-06 Biotronik Vi Patent Ag Implantat mit einem Grundkörper aus einer biokorrodierbaren Legierung
US7998192B2 (en) 2008-05-09 2011-08-16 Boston Scientific Scimed, Inc. Endoprostheses
US8236046B2 (en) 2008-06-10 2012-08-07 Boston Scientific Scimed, Inc. Bioerodible endoprosthesis
DE102008002471A1 (de) 2008-06-17 2009-12-24 Biotronik Vi Patent Ag Stent mit einer Beschichtung oder einem Grundkörper, der ein Lithiumsalz enthält, und Verwendung von Lithiumsalzen zur Restenoseprophylaxe
DE102008040573A1 (de) 2008-07-21 2010-01-28 Biotronik Vi Patent Ag Aptamer beschichtetes Implantat, Herstellverfahren und Verwendungen
DE102008040572A1 (de) 2008-07-21 2010-01-28 Biotronik Vi Patent Ag Implantat mit Beschichtung
DE102008040786A1 (de) 2008-07-28 2010-02-04 Biotronik Vi Patent Ag Biokorrodierbares Implantat mit einer Beschichtung enthaltend eine wirkstofftragende Polymermatrix
DE102008040787A1 (de) 2008-07-28 2010-02-04 Biotronik Vi Patent Ag Biokorrodierbares Implantat mit einer Beschichtung enthaltend ein Hydrogel
US7985252B2 (en) 2008-07-30 2011-07-26 Boston Scientific Scimed, Inc. Bioerodible endoprosthesis
US9119906B2 (en) 2008-09-24 2015-09-01 Integran Technologies, Inc. In-vivo biodegradable medical implant
DE102008042576A1 (de) 2008-10-02 2010-04-08 Biotronik Vi Patent Ag Biokorrodierbare Magnesiumlegierung
US8382824B2 (en) 2008-10-03 2013-02-26 Boston Scientific Scimed, Inc. Medical implant having NANO-crystal grains with barrier layers of metal nitrides or fluorides
DE102008043277A1 (de) 2008-10-29 2010-05-06 Biotronik Vi Patent Ag Implantat aus einer biokorrodierbaren Eisen- oder Magnesiumlegierung
DE102008043736A1 (de) 2008-11-14 2010-05-20 Biotronik Vi Patent Ag Biokorrodierbares Implantat mit einer Wirkstoff-enthaltenden Beschichtung
DE102008043970A1 (de) 2008-11-21 2010-05-27 Biotronik Vi Patent Ag Verfahren zur Herstellung einer korrosionshemmenden Beschichtung auf einem Implantat aus einer biokorrodierbaren Magnesiumlegierung sowie nach dem Verfahren hergestelltes Implantat
DE102008044221A1 (de) 2008-12-01 2010-06-02 Biotronik Vi Patent Ag Stent mit einer Struktur aus einem biokorrodierbaren Werkstoff und einem gesteuerten Korrosionsverhalten
EP2213314B1 (de) 2009-01-30 2016-03-23 Biotronik VI Patent AG Implantat mit einem Grundkörper aus einer biokorrodierbaren Magnesiumlegierung
EP2403546A2 (de) 2009-03-02 2012-01-11 Boston Scientific Scimed, Inc. Selbstpufferende medizinische implantate
DE102009002153A1 (de) * 2009-04-02 2010-10-21 Biotronik Vi Patent Ag Implantat aus einem biokorrodierbaren metallischen Werkstoff mit einer nanopartikel-haltigen Silanbeschichtung und dazugehöriges Herstellungsverfahren
US8435281B2 (en) 2009-04-10 2013-05-07 Boston Scientific Scimed, Inc. Bioerodible, implantable medical devices incorporating supersaturated magnesium alloys
DE102009025511A1 (de) * 2009-06-19 2010-12-23 Qualimed Innovative Medizin-Produkte Gmbh Implantat mit einem vom Körper resorbierbaren metallischen Werkstoff
EP2266507B1 (de) 2009-06-22 2015-07-29 Biotronik VI Patent AG Stent mit verbessertem Stentdesign
EP2266638A3 (de) 2009-06-25 2014-08-13 Biotronik VI Patent AG Biokorrodierbares Implantat mit einer aktiven Beschichtung
EP2266508A1 (de) * 2009-06-25 2010-12-29 Biotronik VI Patent AG Stent mit verbessertem Stentdesign
EP2944332B1 (de) 2009-07-10 2016-08-17 Boston Scientific Scimed, Inc. Verwendung von nanokristallen für einen wirkstofffreisetzungsballon
US10080821B2 (en) * 2009-07-17 2018-09-25 Boston Scientific Scimed, Inc. Nucleation of drug delivery balloons to provide improved crystal size and density
US20110034990A1 (en) * 2009-08-06 2011-02-10 Alexander Borck Biocorrodible implant with active coating
EP2289575B1 (de) 2009-08-06 2017-07-05 Biotronik VI Patent AG Medizinisches Implantat enthaltend eine antioxidative Substanz
WO2011051424A1 (en) 2009-10-30 2011-05-05 Acrostak Corp Bvi, Tortola Biodegradable implantable medical devices formed from super - pure magnesium-based material
WO2011081712A1 (en) * 2009-12-31 2011-07-07 Boston Scientific Scimed, Inc. Cryo activated drug delivery and cutting balloons
US8668732B2 (en) 2010-03-23 2014-03-11 Boston Scientific Scimed, Inc. Surface treated bioerodible metal endoprostheses
WO2011117298A1 (en) 2010-03-25 2011-09-29 Biotronik Ag Implant made of a biodegradable magnesium alloy
EP2371404A3 (de) 2010-03-30 2014-08-20 Biotronik AG Medizinisches Implantat mit einer Beschichtung bestehend aus oder enthaltend mindestens einen Nitro-Statin-Wirkstoff
DE102010018541A1 (de) * 2010-04-28 2011-11-03 Acandis Gmbh & Co. Kg Verfahren zur Herstellung einer medizinischen Vorrichtung
US9072618B2 (en) 2010-05-06 2015-07-07 Biotronik Ag Biocorrodable implant in which corrosion may be triggered or accelerated after implantation by means of an external stimulus
ES2522265T3 (es) 2010-06-21 2014-11-14 Zorion Medical, Inc. Implantes bioabsorbibles
US9561308B2 (en) 2010-06-25 2017-02-07 Fort Wayne Metal Research Products Corporation Biodegradable composite wire for medical devices
SG10201606408SA (en) 2010-08-30 2016-09-29 Sinusys Corp Devices and methods for dilating a paranasal sinus opening and for treating sinusitis
EP2611476B1 (de) 2010-09-02 2016-08-10 Boston Scientific Scimed, Inc. Beschichtungsverfahren für wirkstofffreisetzungsballons mit wärmeinduziertem rewrap-gedächtnis
EP2438891A1 (de) 2010-10-08 2012-04-11 Biotronik AG Stent mit erhöhter Sichtbarkeit im Röntgenbild
EP2446863A1 (de) 2010-10-29 2012-05-02 Biotronik AG Stent mit radial asymmetrischer Kraftverteilung
US8961592B2 (en) 2010-11-12 2015-02-24 Biotronik Ag Functionalized RGD peptidomimetics and their manufacture, and implant having a coating containing such functional-ized RGD peptidomimetics
DE102010043814A1 (de) 2010-11-12 2012-05-16 Biotronik Ag Funktionalisierte RGD-Peptidmimetika und deren Herstellung sowie Implantat mit einer Beschichtung, die solche funktionalisierte RGD-Peptidmimetika enthält
EP2452702B1 (de) 2010-11-12 2015-03-04 Biotronik AG Funktionalisierte RGD-Peptidmimetika und deren Herstellung sowie Implantat mit einer Beschichtung, die solche funktionalisierte RGD-Peptidmimetika enthält
US8986369B2 (en) 2010-12-01 2015-03-24 Zorion Medical, Inc. Magnesium-based absorbable implants
US20120158123A1 (en) 2010-12-15 2012-06-21 Biotronik Ag Polymer stent
TWI548427B (zh) 2010-12-21 2016-09-11 星瑟斯有限公司 含有生物可降解鎂系合金之醫療植入物及其製造方法
DE202011001927U1 (de) 2011-01-25 2011-04-07 Sellin, Lothar Naturstent
US8669360B2 (en) 2011-08-05 2014-03-11 Boston Scientific Scimed, Inc. Methods of converting amorphous drug substance into crystalline form
RU2642254C2 (ru) 2011-08-15 2018-01-24 Меко Лазерштраль-Материальбеарбайтунген Е.К. Рассасывающие стенты, которые содержат магниевые сплавы
WO2013028208A1 (en) 2011-08-25 2013-02-28 Boston Scientific Scimed, Inc. Medical device with crystalline drug coating
EP2630978B1 (de) * 2012-02-22 2018-10-31 Biotronik AG Implantat und verfahren zur herstellung desselben
WO2013130468A1 (en) 2012-02-29 2013-09-06 SinuSys Corporation Devices and methods for dilating a paranasal sinus opening and for treating sinusitis
US10246763B2 (en) 2012-08-24 2019-04-02 The Regents Of The University Of California Magnesium-zinc-strontium alloys for medical implants and devices
DE102012018816A1 (de) 2012-09-25 2014-03-27 Mdi Dental- Und Implantattechnik Gmbh Pharmazeutische Beschichtung für Aufbauten von Zahnimplantaten
US9504554B2 (en) 2013-01-16 2016-11-29 Biotronik Ag Microstructured absorbable implant
US9687263B2 (en) 2013-05-30 2017-06-27 SinuSys Corporation Devices and methods for inserting a sinus dilator
EP2992925B1 (de) 2014-09-04 2022-09-07 BIOTRONIK SE & Co. KG Intravaskuläre elektrodenleitung und intravaskuläre stimulationsvorrichtung damit
JP6089053B2 (ja) * 2015-03-16 2017-03-01 有限会社エスク 防食能を有する生分解性金属表面修飾ステント
DE102016007176A1 (de) 2015-06-11 2017-01-12 Meotec GmbH & Co. KG Resorbierbares Implantat mit hoher Reinheit und guten mechanischen Eigenschaften
US10842911B2 (en) 2015-08-20 2020-11-24 Fuji Light Metal Co., Ltd. Alloy member usable in organisms and production method therefor
EP3342433A1 (de) 2016-12-27 2018-07-04 MeKo Laserstrahl-Materialbearbeitungen e.K. Stent aus einer biologisch abbaubaren magnesiumlegierung mit einer magnesiumfluorid-beschichtung und einer organischen beschichtung
DE202018001853U1 (de) 2018-04-12 2018-06-14 Lothar Sellin Bioresorbierbares Implantat

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4610241A (en) * 1984-07-03 1986-09-09 Gordon Robert T Atherosclerosis treatment method
EP0518061A2 (de) * 1991-05-23 1992-12-16 REHAU AG + Co Medizinische Arbeitsmittel
EP0770391A2 (de) * 1995-10-26 1997-05-02 L'oreal Verwendung von Lanthanide-, Zinn-, Mangan-, Yttrium-, Kobalt-, Barium-, Strontiumsalzen in pharmazeutische Zubereitungen
US6478815B1 (en) * 2000-09-18 2002-11-12 Inflow Dynamics Inc. Vascular and endoluminal stents
WO2002100452A1 (de) * 2001-06-11 2002-12-19 Medizinische Hochschule Hannover Medizinisches implantat für den menschlichen oder tierischen körper

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2219056A (en) * 1938-11-30 1940-10-22 Magnesium Dev Corp Magnesium base alloy
FR1412298A (fr) * 1963-10-26 1965-09-24 Fuchs Otto Procédé pour améliorer les propriétés mécaniques et la résistance à l'oxydation d'alliages de magnésium renfermant du zirconium et alliages fabriqués suivant ce procédé
GB1237035A (en) * 1969-08-20 1971-06-30 Tsi Travmatologii I Ortopedii Magnesium-base alloy for use in bone surgery
AU544762B2 (en) 1981-03-25 1985-06-13 Luxfer Group Limited Magnesium base rare earth alloy
AU3708495A (en) * 1994-08-01 1996-03-04 Franz Hehmann Selected processing for non-equilibrium light alloys and products
US6102904A (en) * 1995-07-10 2000-08-15 Interventional Technologies, Inc. Device for injecting fluid into a wall of a blood vessel
US5807404A (en) * 1996-09-19 1998-09-15 Medinol Ltd. Stent with variable features to optimize support and method of making such stent
DE19731021A1 (de) * 1997-07-18 1999-01-21 Meyer Joerg In vivo abbaubares metallisches Implantat
US6206916B1 (en) * 1998-04-15 2001-03-27 Joseph G. Furst Coated intraluminal graft
EP0966979B1 (de) * 1998-06-25 2006-03-08 Biotronik AG Implantierbare, bioresorbierbare Gefässwandstütze, insbesondere Koronarstent
US6264595B1 (en) * 1999-02-04 2001-07-24 Mobeta, Inc. Radioactive transition metal stents
EP1175236A1 (de) * 1999-04-23 2002-01-30 Agion Technologies, L.L.C. Stent mit antimikrobiellem mittel
US8888688B2 (en) * 2000-04-03 2014-11-18 Intuitive Surgical Operations, Inc. Connector device for a controllable instrument
US6716444B1 (en) * 2000-09-28 2004-04-06 Advanced Cardiovascular Systems, Inc. Barriers for polymer-coated implantable medical devices and methods for making the same
US6979347B1 (en) * 2000-10-23 2005-12-27 Advanced Cardiovascular Systems, Inc. Implantable drug delivery prosthesis
WO2002065945A1 (en) * 2001-02-23 2002-08-29 Angiogene Inc. Use of occlusion device for the local delivery of biologically active dna therapeutic compounds for treating aneurysms and use thereof
DE10118603A1 (de) * 2001-04-12 2002-10-17 Gerd Hausdorf Biologisch abbaubare medizinische Implantate aus der Kombination von metallischen und nichtmetallischen Werkstoffen
DE10163106A1 (de) * 2001-12-24 2003-07-10 Univ Hannover Medizinische Implantate, Prothesen, Protheseteile, medizinische Instrumente, Geräte und Hilfsmittel aus einem halogenid-modifizierten Magnesiumwerkstoff
IL147561A (en) * 2002-01-10 2005-03-20 Dead Sea Magnesium Ltd High temperature resistant magnesium alloys
DE10207161B4 (de) * 2002-02-20 2004-12-30 Universität Hannover Verfahren zur Herstellung von Implantaten
AU2003241515A1 (en) * 2002-05-20 2003-12-12 Orbus Medical Technologies Inc. Drug eluting implantable medical device
DE10253634A1 (de) * 2002-11-13 2004-05-27 Biotronik Meß- und Therapiegeräte GmbH & Co. Ingenieurbüro Berlin Endoprothese
DE10361942A1 (de) * 2003-12-24 2005-07-21 Restate Patent Ag Radioopaker Marker für medizinische Implantate
DE102004026104A1 (de) * 2004-05-25 2005-12-15 Restate Patent Ag Implantat zur Gefäßligatur
DE102004043231A1 (de) * 2004-09-07 2006-03-09 Biotronik Vi Patent Ag Endoprothese aus einer Magnesiumlegierung
DE102004043232A1 (de) * 2004-09-07 2006-03-09 Biotronik Vi Patent Ag Endoprothese aus einer Magnesiumlegierung
DE102005003188A1 (de) * 2005-01-20 2006-07-27 Restate Patent Ag Medizinisches Implantat aus einer amorphen oder nanokristallinen Legierung
US20080138236A1 (en) * 2005-03-08 2008-06-12 G. Alloy Technology Co, Ltd. Mg Alloys Containing Misch Metal Manufacturing Method of Wrought Mg Alloys Containing Misch Metal, and Wrought Mg Alloys Thereby
US7869858B2 (en) * 2005-05-12 2011-01-11 General Electric Company Patient table system and apparatus
TW200643188A (en) * 2005-05-26 2006-12-16 Cast Centre Pty Ltd Hpdc magnesium alloy
DE102006015457A1 (de) * 2006-03-31 2007-10-04 Biotronik Vi Patent Ag Magnesiumlegierung und dazugehöriges Herstellungsverfahren
DE102006038237A1 (de) * 2006-08-07 2008-02-14 Biotronik Vi Patent Ag Markerlegierung
IL177568A (en) * 2006-08-17 2011-02-28 Dead Sea Magnesium Ltd Creep resistant magnesium alloy with improved ductility and fracture toughness for gravity casting applications
US20080183278A1 (en) * 2007-01-26 2008-07-31 Boston Scientific Scimed, Inc. Implantable medical endoprostheses
WO2008098922A2 (en) * 2007-02-13 2008-08-21 Cinvention Ag Biodegradable porous stent

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4610241A (en) * 1984-07-03 1986-09-09 Gordon Robert T Atherosclerosis treatment method
EP0518061A2 (de) * 1991-05-23 1992-12-16 REHAU AG + Co Medizinische Arbeitsmittel
EP0770391A2 (de) * 1995-10-26 1997-05-02 L'oreal Verwendung von Lanthanide-, Zinn-, Mangan-, Yttrium-, Kobalt-, Barium-, Strontiumsalzen in pharmazeutische Zubereitungen
US6478815B1 (en) * 2000-09-18 2002-11-12 Inflow Dynamics Inc. Vascular and endoluminal stents
WO2002100452A1 (de) * 2001-06-11 2002-12-19 Medizinische Hochschule Hannover Medizinisches implantat für den menschlichen oder tierischen körper

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
BERND HEUBLEIN, ROLAND ROHDE, MATHIAS NIEMEYER, VOLKER KASSE ET AL.: "Degradation of Metallic Alloys - A new Principle in Stent Technology?", ABSTRACTS-ACCIS 2000, February 2000 (2000-02-01), 02-2000, pages 14A - 15A, XP002291050 *

Also Published As

Publication number Publication date
EP1562565B1 (de) 2008-03-12
ATE316390T1 (de) 2006-02-15
US20040098108A1 (en) 2004-05-20
AU2003288029A1 (en) 2004-06-03
DE50309382D1 (de) 2008-04-24
US20060246107A1 (en) 2006-11-02
AU2003288029A8 (en) 2004-06-03
EP1419793B1 (de) 2006-01-25
US8425835B2 (en) 2013-04-23
JP2004160236A (ja) 2004-06-10
US20100119576A1 (en) 2010-05-13
EP1419793A1 (de) 2004-05-19
EP1562565A2 (de) 2005-08-17
ATE388696T1 (de) 2008-03-15
DE10253634A1 (de) 2004-05-27
US20100034899A1 (en) 2010-02-11
JP5073913B2 (ja) 2012-11-14
DE50302281D1 (de) 2006-04-13
WO2004043474A2 (de) 2004-05-27

Similar Documents

Publication Publication Date Title
WO2004043474A3 (de) Verwendung eines oder mehrerer der elemente aus der gruppe yttrium, neodym und zirconium
EP2305213A3 (de) Behandlung von Dünndarm-Bakterienwucherung und damit in Zusammenhang stehenden Zustände
IL171683A (en) Immunosuppressive Compounds, Medicinal Products Containing Them and Their Use in the Preparation of Medication for Treatment
WO2004006858A3 (en) Compounds, compositions, and methods employing same
AU2003239609A1 (en) 2-Furancarboxylic acid hydrazides and pharmaceutical compositions containing the same
AU2003274681A1 (en) Dosage form comprising high dose high soluble active ingredient as modified release and low dose active ingredient as immediate release
IL163894A (en) 2-hydroxy-3-heteroarylindole derivatives, pharmaceutical compositions comprising them and their uses in the preparation of medicaments
IL163552A (en) Conjugates of biologically active compounds, uses thereof and pharmaceutical compositions comprising the same
ECSP083351A (es) Composiciones farmacéuticas
IL162765A (en) Diazabicycle derivatives, processes for their preparation, pharmaceutical compositions comprising them and their medical use
HUP0401109A3 (en) Nociceptin analogs, their use and pharmaceutical compositions containing them
IL173369A (en) Combined pharmaceutical preparation containing g - csf and p1gf effective in stimulating mobilization of peripheral blood progenitor cells
TW200503782A (en) New formulations and use thereof
ZA200303037B (en) Herbal pharmaceutical composition for treatment of HIV/Aids patients.
HK1088225A1 (en) Compositions comprising immunomodulatory compoundsfor treatment, modification and management of pai n
BG108516A (en) Pharmaceutical formulation
EP1435982A4 (de) System zur abgabe von pharmazeutischen, ernährungs- und kosmetischen inhaltsstoffen
AU2003297199A8 (en) Human chondroitinase glycoprotein (chasegp), process for preparing the same, and pharmaceutical compositions comprising thereof
HUP0402318A3 (en) Pharmaceutical composition comprising cyclosporin and use thereof
AU2003236156A1 (en) Pharmaceutical compositions used for immune disease treatment and improvement
DE60202590D1 (de) 2h-1-benzopyran-derivate, prozesse zu ihrer herstellung und pharmazeutische zusammensetzungen
HUP0303469A3 (en) Phtalazinon-derivatives, their use and pharmaceutical compositions containing them
HUP0201696A2 (en) Cyclic peptides, pharmaceutical compositions comprising thereof and their use
IL184131A0 (en) Pyrido (3,2-d)pyrimidines and pharmaceutical compositions useful for medical treatment
PL1663101T3 (pl) Postać stosowana do doustnego podawania substancji czynnych, witamin i/lub substancji odżywczych, zestaw i zastosowanie

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2003779881

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2003779881

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2006246107

Country of ref document: US

Ref document number: 10535084

Country of ref document: US

NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP

WWP Wipo information: published in national office

Ref document number: 10535084

Country of ref document: US

WWG Wipo information: grant in national office

Ref document number: 2003779881

Country of ref document: EP